Contemporary Management of Complex Skin Cancers 2019

The purpose of this course is to provide the attendee with a multidisciplinary management approach for patients with skin cancer, including basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma, melanoma and other complex skin cancers. The topics will focus on advances in epidemiology, pathology and imaging, medical and surgical management and radiation therapy. Complex skin cancer cases will be presented and discussed in a tumor board style with a multidisciplinary panel of experts.

The target audience includes physicians and allied health professionals, who care for patients with skin cancer, including dermatologists, surgical and medical oncologists, otolaryngologists, ophthalmologists, general surgeons, plastic surgeons, pathologists and radiation oncologists.

Reflectance Confocal Microscopy Workshop | Friday, November 1, 4:45–5:45 pm

Reflectance confocal microscopy (RCM) is a non-invasive device that images skin lesions at high resolution in vivo similar to traditional pathology. RCM has shown high sensitivity and specificity for detection of skin cancers (melanocytic and non-melanocytic). RCM has recently been granted Category I Current Procedural Terminology (CPT) reimbursement codes by the Centers for Medicare and Medicaid Services. RCM is now advancing as an add-on diagnostic tool to dermoscopy in clinics in the U.S., for early detection of skin cancers, while sparing un-necessary benign diagnosis. To expand RCM role in the clinical practice, there is a need for training a new generation of physicians - the future Confocalists. Pre-registration is required and space is limited. Please note that CME credit will not be offered for the Reflectance Confocal Microscopy Workshop.

1. Describe melanoma and non melanoma skin cancer incidence and behavior
2. Define factors contributing to behavior and outcome of skin cancers
3. Define characteristics of skin cancers that require aggressive treatment
4. Understand benefits, limitations, and integration of different modalities used in the treatment of skin
5. Review novel approaches to optimize surgical treatment of skin cancers
6. Assess role and variety of radiotherapeutic approaches to complex skin cancers
7. Review role of biological therapy in the treatment of advanced skin cancers
8. Examine the optimal approaches toward reconstruction of defects resulting from resection of skin

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Registration Discounts/Promotions

• MSK CME offers a discounted rate for MSK Alumni, MSK Cancer Alliance and Cancer Care Partners. If you are a member of one of these groups, please contact [email protected] for more information.
• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected].

Please note: after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

MSK Course Directors

Kishwer S. Nehal, MD
Director, Mohs Micrographic and Dermatologic Surgery
Attending Physician, Dermatology Service
Department of Medicine

Bhuvanesh Singh, MD, PhD
Director, Laboratory of Epithelial Cancer Biology
Attending Surgeon, Head & Neck Service
Department of Surgery

Invited Course Faculty 

Chrysalyne D. Schmults, MD, MSCE
Associate Professor of Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Brigham and Women’s Faulkner Hospital/Dana-Farber Cancer Institute
Boston, MA

MSK Course Faculty 

Faculty Disclosures (All Faculty) 

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants and financial support for this live activity:

• Cardinal Health
  
• Regeneron Pharmaceuticals, Inc.
• Tiemann Surgical